Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Product sales $ 4 $ 0 $ 4 $ 0
Operating cost and expense        
Cost of product sales 1,048 2,138 2,043 3,749
Research and development cost 521 176 1,072 465
General and administrative expense 2,390 2,129 5,154 4,428
Total operating expense 3,959 4,443 8,269 8,642
Loss from operations (3,955) (4,443) (8,265) (8,642)
Other income and (expense)        
Insurance proceeds net of related expenses 0 460 0 448
PPP loan forgiveness 0 201 0 332
Gain (loss) on disposal of property and equipment 739 (4,254) 590 (4,254)
Interest expense (12) (4) (12) (9)
Interest and other income 62 24 113 25
Total other income (expense), net 789 (3,573) 691 (3,458)
Loss before income tax expense (3,166) (8,016) (7,574) (12,100)
Income tax expense 0 0 (2) (2)
Net loss $ (3,166) $ (8,016) $ (7,576) $ (12,102)
Weighted average shares outstanding, basic and diluted (in shares) 75,215,009 68,152,296 73,584,761 67,518,650
Basic and diluted net loss per share (in dollars per share) $ (0.04) $ (0.12) $ (0.10) $ (0.18)